...
首页> 外文期刊>Leukemia and lymphoma >Upon drug-induced apoptosis in lymphoma cells X-linked inhibitor of apoptosis (XIAP) translocates from the cytosol to the nucleus.
【24h】

Upon drug-induced apoptosis in lymphoma cells X-linked inhibitor of apoptosis (XIAP) translocates from the cytosol to the nucleus.

机译:在药物诱导的淋巴瘤细胞凋亡中,X连锁凋亡抑制剂(XIAP)从胞质溶胶转移到细胞核。

获取原文
获取原文并翻译 | 示例

摘要

The X-linked inhibitor of apoptosis (XIAP) and cellular inhibitor of apoptosis-1 (cIAP-1) are emerging as versatile proteins in programmed cell death with a scope of possible functions reaching far beyond their well known inhibitory effects on caspases. We previously demonstrated that the ability of drugs to modify expression and cleavage of the IAPs are crucial for the synergistic effects achieved by the combinations of different cytotoxic drugs employed to treat malignant lymphomas. In order to more clearly assess the underlying molecular mechanisms, we here evaluated the consequences of drug-induced apoptosis on the localization and aggregation of XIAP and cIAP-1. The influence of drug-induced apoptosis on localization of IAPs was investigated using immunofluorescence microscopy as well as western blot analysis. Apoptosis was induced by chemotherapeutic drugs with different modes of action (bendamustine, cladribine, fludarabine, doxorubicin and mitoxantrone) and assessed by flow-cytometry using Annexin V. We demonstrate that XIAP and cIAP-1 are downregulated and/or cleaved in a dose-dependent manner upon treatment with a variety of anti-cancer drugs. Moreover we provide evidence that in the context of drug-induced apoptosis XIAP, its BIR3-RING cleavage product and cIAP-1 undergo an extensive change of subcellular localization. Immunofluorescence microscopy reveals that XIAP, in contrast to cIAP-1, is located in discrete cytosolic protein aggregates and-upon induction of apoptosis with cytotoxic drugs--redistributes into large nuclear inclusions. This translocation of XIAP and its BIR3-RING cleavage product from the cytosol into the nucleus is confirmed by cell fractionation and western blot analyses. Of note, in this experimental setting putative interaction partners of XIAP-such as Apaf-1, caspase-3 and -7--do not co-localize with XIAP. These results imply a new unknown function of XIAP and its BIR3-RING fragment in the nucleus in the context of drug-induced apoptosis. The localization of cIAP-1 inmitochondria and its liberation from these indicate a profoundly different function of this protein despite its similar modular structure to XIAP.
机译:X连锁的细胞凋亡抑制剂(XIAP)和细胞凋亡的细胞凋亡抑制剂1(cIAP-1)在程序性细胞死亡中正在作为通用蛋白出现,其可能的功能范围远远超出了它们对胱天蛋白酶的抑制作用。我们先前证明,药物修饰IAP的表达和裂解的能力对于通过组合使用多种细胞毒性药物来治疗恶性淋巴瘤所获得的协同效应至关重要。为了更清楚地评估潜在的分子机制,我们在这里评估了药物诱导的凋亡对XIAP和cIAP-1的定位和聚集的影响。使用免疫荧光显微镜和蛋白质印迹分析研究了药物诱导的凋亡对IAPs定位的影响。凋亡是由具有不同作用方式(苯达莫司汀,克拉屈滨,氟达拉滨,阿霉素和米托蒽醌)的化学治疗药物诱导的,并使用膜联蛋白V通过流式细胞术评估。我们证明XIAP和cIAP-1在剂量下降低和/或裂解依赖于各种抗癌药的治疗方式。此外,我们提供的证据表明,在药物诱导的细胞凋亡XIAP中,其BIR3-RING裂解产物和cIAP-1经历了亚细胞定位的广泛变化。免疫荧光显微镜检查发现,与cIAP-1相比,XIAP位于离散的胞浆蛋白聚集物中,并且在被细胞毒性药物诱导凋亡后重新分布到大的核内含物中。 XIAP及其BIR3-RING裂解产物从胞质溶胶向核内的这种易位通过细胞分级分离和Western印迹分析得到证实。值得注意的是,在此实验环境中,XIAP的假定相互作用伙伴(例如Apaf-1,caspase-3和-7)不会与XIAP共同定位。这些结果暗示在药物诱导的细胞凋亡的背景下,XIAP及其BIR3-RING片段在细胞核中具有新的未知功能。尽管cIAP-1线粒体的定位及其从XIAP的相似的模块化结构,但它们的释放表明该蛋白的功能截然不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号